ID: ALA2333979

Max Phase: Preclinical

Molecular Formula: C57H109NO10

Molecular Weight: 968.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)NC[C@H]1O[C@H](OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)[C@@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C57H109NO10/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-51(59)58-46-50-54(62)55(63)56(64)57(68-50)66-48-49(67-53(61)45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)47-65-52(60)44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h49-50,54-57,62-64H,4-48H2,1-3H3,(H,58,59)/t49-,50-,54-,55+,56+,57+/m1/s1

Standard InChI Key:  FQQGDOIXTUYSNI-YYOMRMLRSA-N

Associated Targets(Human)

Myelin transcription factor 1 62 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 968.50Molecular Weight (Monoisotopic): 967.8051AlogP: 13.83#Rotatable Bonds: 50
Polar Surface Area: 160.85Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.22CX Basic pKa: CX LogP: 16.42CX LogD: 16.42
Aromatic Rings: 0Heavy Atoms: 68QED Weighted: 0.03Np Likeness Score: 0.45

References

1. Rohe A, Göllner C, Wichapong K, Erdmann F, Al-Mazaideh GM, Sippl W, Schmidt M..  (2013)  Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.,  61  [PMID:22770610] [10.1016/j.ejmech.2012.06.007]

Source